CSIMarket Company Name, Ticker, Competitors, else..
 
Evofem Biosciences Inc   (EVFM)
 

Evofem Biosciences Inc's Suppliers Performance

EVFM's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
EVFM Costs vs Sales of Suppliers Growth Evofem Biosciences Inc's cost of sales deteriorated by -32.32 % year on year, sequentially cost of sales grew by 24.63 % in Q2.

• More on EVFM Suppliers



Evofem Biosciences Inc's cost of sales deteriorated by -32.32 % year on year, sequentially cost of sales grew by 24.63 % in Q2.

• More on EVFM Suppliers




Evofem Biosciences Inc's Comment on Supply Chain


The company outsources the manufacturing of PHEXX to a third-party manufacturer and is currently contracted with a US-based gel manufacturer to produce PHEXX in compliance with cGMP regulations and other applicable laws. As of December 31, 2025, the company held inventory sufficient to support approximately three months of anticipated demand for PHEXX, with additional manufacturing in progress. Finished goods inventory of SOLOSEC was acquired from the SOLOSEC seller at a predetermined unit price. The company plans to outsource future manufacturing of SOLOSEC to a third party, similar to its arrangement for PHEXX.

Evofem Biosciences Inc's Comment on Supply Chain


The company outsources the manufacturing of PHEXX to a third-party manufacturer and is currently contracted with a US-based gel manufacturer to produce PHEXX in compliance with cGMP regulations and other applicable laws. As of December 31, 2025, the company held inventory sufficient to support approximately three months of anticipated demand for PHEXX, with additional manufacturing in progress. Finished goods inventory of SOLOSEC was acquired from the SOLOSEC seller at a predetermined unit price. The company plans to outsource future manufacturing of SOLOSEC to a third party, similar to its arrangement for PHEXX.







EVFM's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Evofem Biosciences Inc 1.06 18.05 -15.28 29
SUBTOTAL 0.00 0.00 0.00 -


Sources: Evofem Biosciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Evofem Biosciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.